IPCEI Tech4Cure

IPCEI Tech4Cure is a European initiative focused on developing innovative active implantable medical devices (AIMDs) with advanced digital and AI solutions to advance predictive, preventive, and personalized medicine. The program aims to structure the European AIMD sector for public health and industrial autonomy, involving multiple companies across six EU states, including France, Hungary, Italy, Slovakia, and Slovenia, which jointly notified the program. FineHeart, led by CEO Arnaud Mascarell, serves as a key participant, having secured €48 million in grants from the initiative, contributing to its total €83 million raised. Another significant participant, Powerful Medical, was awarded over €40 million in grants. The Tech4Cure wave was authorized after May 28, 2024, with project notifications expected in 2025. Its business model centers on funded through non-dilutive grants from the European Commission’s IPCEI program, jointly notified by EU member states including France, Hungary, Italy, Slovakia, and Slovenia.